Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
इंदौर [मध्य प्रदेश, भारत], 16 अगस्त: जब एक ही कक्षा के कई बच्चे पढ़ने में…
Yandina, Australia (dpa) – The last macadamia nuts of the season lie on the ground.…
इंदौर [मध्य प्रदेश, भारत], 16 अगस्त: जब एक ही कक्षा के कई बच्चे पढ़ने में…
Barcelona (dpa) – Climate change is hitting the cities of Europe hard and fast, with…
Berlin (dpa) – Ginger shots have been all the rage for years, whether for people…
Berlin (dpa) – Fans of cooking videos may have heard that special crunch when someone…